PYCR1 and prostate cancer: Increasing evidence suggests that PYCR1 is highly expressed in various cancers, such as prostate cancer (Zeng et al. 2017), non-small cell lung cancer (NSCLC) (Cai et al. 2018) and hepatocellular cancer (Zhuang et al. 2019).